06609.HK
Shanghai HeartCare Medical Technology Corporation Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 45.18
−1.61%Year over year
Reported trailing growth
- Revenue
- +46.9%
- EBITDA
- +882.0%
- EBIT
- +1631.9%
- EPS
- +713.0%
- Free cash flow
- +2059.7%
- Operating cash flow
- +4866.3%
Forward estimates
Based on analyst estimates
- Revenue
- +9.9%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +30.7%
- EBITDA
- +194.6%
- EBIT
- +810.2%
- Net income
- +711.8%
- EPS
- +713.9%
- Free cash flow
- +1768.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025